Cargando…
Immunotherapy for ocular myasthenia gravis: an observational study in Japan
BACKGROUND: Treatment for ocular myasthenia gravis (OMG) has not yet been well established. Few reports have been published on the clinical practice and outcomes of OMG. OBJECTIVES: We investigated treatment of OMG and its outcomes in Japan.We investigated treatment of OMG and its outcomes in Japan....
Autores principales: | Narita, Tomoko, Nakane, Shunya, Nagaishi, Akiko, Minami, Naoya, Niino, Masaaki, Kawaguchi, Naoki, Murai, Hiroyuki, Kira, Jun-ichi, Shimizu, Jun, Iwasa, Kazuo, Yoshikawa, Hiroaki, Hatanaka, Yuki, Sonoo, Masahiro, Shimizu, Yuko, Matsuo, Hidenori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084546/ https://www.ncbi.nlm.nih.gov/pubmed/37051222 http://dx.doi.org/10.1177/17562864231163819 |
Ejemplares similares
-
Autoantibodies in Japanese patients with ocular myasthenia gravis
por: Nagaishi, Akiko, et al.
Publicado: (2020) -
Association of Smoking and Generalized Manifestations of Myasthenia Gravis
por: Miyazaki, Yusei, et al.
Publicado: (2021) -
Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018
por: Yoshikawa, Hiroaki, et al.
Publicado: (2022) -
CD59 Expression in Skeletal Muscles and Its Role in Myasthenia Gravis
por: Iwasa, Kazuo, et al.
Publicado: (2022) -
Response to treatment of myasthenia gravis according to clinical subtype
por: Akaishi, Tetsuya, et al.
Publicado: (2016)